Asp177 in C4 domain of mouse sphingosine kinase 1a is important for the sphingosine recognition  by Yokota, Shinji et al.
FEBS Letters 578 (2004) 106–110 FEBS 29010Asp177 in C4 domain of mouse sphingosine kinase 1a
is important for the sphingosine recognition
Shinji Yokota, Yuki Taniguchi, Akio Kihara, Susumu Mitsutake, Yasuyuki Igarashi*
Department of Biomembrane and Biofunctional Chemistry, Graduate School of Pharmaceutical Sciences,
Hokkaido University, Kita 12, Nishi 6, Kita-ku, Sapporo 060-0812, Japan
Received 1 October 2004; revised 20 October 2004; accepted 20 October 2004
Available online 11 November 2004
Edited by Gerrit van MeerAbstract Sphingosine kinase (SK) is the enzyme that catalyzes
the formation of sphingosine 1-phosphate (S1P). Although di-
verse biological functions have been reported for SK, its recogni-
tion site for its substrate sphingosine (Sph) is still unclear. We
constructed various mutants of mouse sphingosine kinase 1a
(mSK1a), carrying mutations in the C4 domain, which we had
expected to encompass the Sph-binding site. We analyzed the
inﬂuence of these mutations on the SK activity and substrate
kinetics. One mutation, Asp177ﬁ Asn177, caused a dramatic de-
crease in SK activity (to ~6% of wild type) and an increase in the
Km value for Sph (10.1ﬁ 108 lM), with no change in the aﬃn-
ity for ATP. This result suggests that the C4 domain, especially
the Asp177, is involved in the speciﬁc recognition of Sph. In this
report, we are able, for the ﬁrst time, to provide an account of the
Sph-binding site of SK.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Sphingosine kinase; Sphingosine;
Sphingosine 1-phosphate; Calmodulin1. Introduction
Sphingosine kinase (SK) catalyzes the formation of sphing-
osine 1-phosphate (S1P), a lipid second messenger involved
in mediating diverse and fundamental biological processes
[1]. SK activity can be increased by various stimuli such as tu-
mor necrosis factor-alpha [2,3], phorbol 12-myristate 13-ace-
tate [4], platelet-derived growth factor [5], nerve growth
factor [6,7], and muscarinic acetylcholine agonists [8]. Stimula-
tion induced by these agonists results in a rapid and transient
increase in cellular S1P, whose basal levels are generally low.
Although the intracellular targets of S1P have yet to be deter-
mined, extracellular S1P has been implicated as a ligand for the
S1P receptors [9], initiating cell proliferation, survival [10],
Ca2+ mobilization [11,12], and expression of adhesion mole-
cules [12].Abbreviations: Sph, sphingosine; SK, sphingosine kinase; S1P, sphing-
osine 1-phosphate; mSK1a, mouse sphingosine kinase 1a; DGK,
diacylglycerol kinase; CERK, ceramide kinase; TBS, Tris-buﬀered
saline; CaM-Sepharose, calmodulin/Sepharose 4B
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doi:10.1016/j.febslet.2004.10.081SK was originally cloned in budding yeast [13], but members
of the SK family have been identiﬁed in plant [14], ﬂy [15],
mouse [16], rat [17] and human [18]. All known SKs have ﬁve
highly conserved domains, C1–C5 [16], that are considered to
be involved in the maintenance of the protein structure and the
recognition of substrates. SK has known substrate speciﬁcities
phosphorylating D-erythro-sphingosine and to a lesser extent
D-erythro-dihydrosphingosine but not phytosphingosine
[16,19,20], and the resulting phosphorylation is ATP-depend-
ent [17]. SK activity is also known to be widely distributed
in mouse and rat tissues and, at the cellular level, to reside pre-
dominantly in the cytosol [16], although some activity has been
found in the mitochondrial and microsomal fractions [21].
Recent studies regarding the structural biology of SKs have
revealed three putative calmodulin-binding motifs, which ap-
pear to be Ca2+ and conformation dependent [22]. SKs trans-
locate to the plasma membrane as a result of associating with
calmodulin. However, it remains unclear whether calmodulin
has any important biological roles in the SK activity, as there
was no obvious inﬂuence in an in vitro experiment [23]. Addi-
tionally, studies have reported the presence of other motifs,
such as the nuclear export signal detected in SK1 [24], and
the nuclear localization signal [25], proline rich domain [26],
and SH3 binding motif detected in the C-terminus region
[27] in SK2. To date, though, no studies have been reported
regarding the interaction of SKs with sphingosine (Sph).
Therefore, we set out to identify the Sph-binding site in mouse
sphingosine kinase 1a (mSK1a), using mutagenesis and analy-
sis of the substrate kinetics.
According to a previous report, the C1–C3 domains of SKs
exhibit high homology with protein kinases, and the consensus
sequence SGDGx1721K in the C2–C3 domain is an ATP-
binding site with similarity to a highly conserved glycine-rich
loop [28] found in many such kinases. The C5 domain is highly
conserved, not only in the SKs but also in lipid kinases such as
the ceramide kinases (CERKs) [29] and the diacylglycerol kin-
ases (DGKs) [30], whereas the C4 domain is highly conserved
only in SKs (Fig. 1). Thus, we considered the C4 domain as a
speciﬁc recognition site for Sph. So we examined whether this
domain was involved.2. Materials and methods
2.1. Construction of mSK1a mutants
Wild-type mSK1a (mSK1aWT) (GenBanke Accession No.
AAL07499) was FLAG epitope-tagged at the 5 0-end and subcloned
into a pcDNA3 site-directed mutagenesis vector (Invitrogen Corp.,ation of European Biochemical Societies.
Fig. 1. A partial sequence alignment of SKs. Protein sequences were aligned using the ClustalW method from DNA Data Bank of Japan (DDBJ).
Identical amino acids across all aligned proteins are highlighted in black and highly conserved amino acids are highlighted in gray. The left ﬁgure
shows a sequence alignment of the C4 domain of SKs and the site where we constructed mutants. The right ﬁgure shows a sequence alignment
between the C5 domains of SKs, CERKs and DGKs.
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plate for oligonucleotide-directed mutagenesis as detailed in the man-
ufacturers protocol. The mutagenic oligonucleotides used to generate
the point mutant constructs were: for mSK1aD175N, F, 5 0-GGCTTTG-
TTGCTAACGTCGACCTCGAG-3 0; R, 5 0-CTCGAGGTCGACGT-
TAGCAACAAAGCC-3 0; mSK1aD177N, F, 5 0-GTTGCTGACGTCA-
ACCTCGAGAGAGTGAG-3 0; R, 5 0-CTCACTCTCGAGGTTGA-
CGTCAGCAAC-3 0; mSK1aE179Q, F, 5 0-GACGTCGACCTCCAGA-
GTGAGAAGTAC-3 0; R, 5 0-GTACTTCTCACTCTGGAGGTCG-
ACGTC-3 0; mSK1aE181Q, F, 5 0-GACCTCGAGAGTCAGAAGTA-
CAGGCGC-3 0; R, 5 0-GCGCCTGTACTTCTGACTCTCGAGGT-
C-3 0; mSK1aD175N/D177N, F, 5 0-TTTGTTGCTAACGTCAACCTC-
GAGAGT-3 0; R, 5 0-ACTCTCGAGGTTGACGTTAGCAACAAA-
3 0; mSK1aD177N/E179Q, F, 5 0-GCTGACGTCAACCTCCAGAGTGA-
GAAG-30; R, 5 0-CTTCTCACTCTGGAGGTTCACGTCAGC-3 0;
The mutants were sequenced to verify incorporation of the desired
modiﬁcation.
2.2. Cell culture and transfection
Human embryonic kidney cells (HEK293; ATCC CRL-1573) were
cultured on collagen-coated dishes in Dulbeccos modiﬁed Eagles
medium D6429 (Sigma–Aldrich Corp., St. Louis, MO) containing
10% (v/v) FBS (Sigma), 100 U/ml penicillin and 100 ng/ml strepto-
mycin (Sigma), at 37 C in 5% CO2. Transfections were performed
using the LipofectAMINE and LipofectAMINE Plus Reagents (Invi-
trogen) following the manufacturers protocol. Cells were harvested
and lysed by sonication (2 W for 30 s at 4 C) in lysis buﬀer (50
mM Tris–HCl (pH 7.4), 10% glycerol, 0.05% Triton X-100, 150
mM NaCl, 1 mM dithiothreitol, 2 mM Na3VO4, 10 mM NaF, 1
mM EDTA and protease inhibitors (Completee; Roche Diagnostics
Corp., Mannheim, Germany)). Protein concentrations of cell lysates
were determined with a BCA Protein Assay Reagent Kit (Pierce Bio-
technology Inc., Rockford, IL) using bovine serum albumin as a
standard.
2.3. Sphingosine kinase assay
Twenty four hours after transfection, cells were harvested as de-
scribed above. A SK assay was performed as described previously
[16] with slight modiﬁcations. The reaction was carried out for 30
min at 37 C in assay buﬀer (20 mM Tris–HCl (pH 7.4), 25 mM
EDTA, 12 mM b-glycerophosphate, 1 mM NaPPi, 5% glycerol, 5
mM Na3VO4, 2 mM dithiothreitol, 0.5 mM 4-deoxypyridoxine
and protease inhibitors), using the cell lysate as the enzyme and
the substrate mixture (50 lM D-erythro-sphingosine (Biomol Re-
search Laboratory Inc., Plymouth Meeting, PA) and 10 lCi of
[c-32P] ATP (10 Ci/mmol; Perkin–Elmer Life Science Inc., Boston,
MA) in 1 mM ﬁnal concentration of ATP in 0.25% Triton
X-100). The lipids were separated by thin-layer chromatography
on silica gel 60 plates (Merck KGaA, Darmstadt, Germany) with
1-butanol/acetic acid/water (3:1:1, v/v), and the labeled S1P was
quantiﬁed by a BAS 2500 imaging analyzer (Fuji Photo Film Co.,
Kanagawa, Japan).
When we performed a SK assay, we used equal amount of protein
and the unit of SK activity was deﬁned as the amount of enzyme re-
quired to produce 1 pmol of S1P/min. The kinetic data were analyzed
using Michaelis–Menten kinetics.2.4. Calmodulin-binding assay
A calmodulin-binding assay was performed as described previously
[22], with slight modiﬁcations. HEK293 cells overexpressing mSK1aWT
or mSK1a mutants were harvested and lysed as described above. The
cell lysates were then centrifuged (100 000 · g, 30 min, 4 C) to remove
debris. Aliquots of the supernatants were added to tubes containing
calmodulin/Sepharose 4B beads (CaM–Sepharose; Amersham Bio-
sciences Corp., Piscataway, NJ), pre-equilibrated with binding buﬀer
(50 mM Tris–HCl (pH 7.4), 200 mM NaCl, 10% glycerol, 0.2% Triton
X-100, 1 mM dithiothreitol, 2 mM Na3VO4, 10 mM NaF and protease
inhibitors). Additional binding buﬀer containing 5 mM CaCl2 or 10
mM EGTA was added to each tube, and the mixtures were incubated
for 2 h at 4 C, with continuous mixing. CaM–Sepharose beads were
then pelleted by centrifugation (3500 · g, 5 min, 4 C), washed twice
with binding buﬀer containing 5 mM CaCl2 or 10 mM EGTA and, ﬁ-
nally, washed in buﬀer without Triton X-100. Proteins were visualized
by Western blotting via their FLAG epitope.
2.5. Western blotting
SDS–PAGE was performed on cell lysates using 12% acrylamide
gels according to the method of Laemmli [31]. Proteins were trans-
ferred to PVDF membranes (Millipore Corp., Bedford, MA) and the
membranes were blocked overnight at 4 C in Tris-buﬀered saline with
0.1% Tween 20 (TBS/T), containing 5% skimmed milk powder. This
was followed by incubation with a 1:1000 dilution of the monoclonal
anti-FLAG antibody M2 (Sigma). The blots were washed with TBS/
T, then incubated with a 1:10 000 dilution of horseradish peroxidase-
conjugated anti-mouse IgG F(ab 0)2 ﬂagment (Amersham). The mSK1a
proteins were detected using an enhanced chemiluminescence (ECL)
kit (Amersham).3. Results
3.1. Asp177ﬁ Asn177 mutation (mSKD177N) decreases
the SK activity
We ﬁrst constructed plasmids of mSK1a mutants to examine
the inﬂuence of the C4 domain on the catalytic reaction. The
constructed plasmids were mutated by substituting Asn or
Gln for the negatively charged Asp175, Asp177, Glu179 and
Glu181 residues, which are highly conserved in the C4 domain
(Fig. 1). Then, an in vitro kinase assay was performed on each
expressed mutant to examine the eﬀects on the enzyme activity.
Although all of the mutants tested exhibited decreased activity
(mSK1aD175N had only half the activity of the wild type and,
mSK1aE179Q and mSK1aE181Q only a quarter), the greatest de-
crease (to 6% that of wild type) was observed in mSK1aD177N
(Fig. 2). Furthermore, we conﬁrmed that the double mutants
mSK1aD175N/D177N and mSK1aD177N/E179Q, which also lack
the Asp177 residue, showed an even greater decline in SK activ-
ity (Fig. 2). Thus, it appears that the region encompassing
Asp177 inﬂuences the mSK1a activity.
Fig. 3. Selective binding to calmodulin indicates that the mSK1a
mutants undergo proper folding. Cell lysates from HEK293 cells
expressing each mSK1a mutant (upper frame) were incubated with
CaM–Sepharose beads in the presence of 5 mM Ca2+ (middle frame)
or 10 mM EGTA (bottom frame), which was used as a control to
account for any non-speciﬁc binding. The beads were then washed and
subjected to SDS–PAGE, and each mSK1a protein bound to CaM–
Sepharose was visualized by Western blotting via the FLAG epitope.
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Fig. 2. Relative SK activities of mSK1a mutants. HEK293 cells
transfected with empty vector, pcDNA3-mSK1aWT, pcDNA3-
mSK1aD175N, pcDNA3-mSK1aD177N, pcDNA3-mSK1aE179Q,
pcDNA3-mSK1aE181Q, pcDNA3-mSK1aD175N/D177N or pcDNA3-
mSK1aD177N/E179Q were harvested and analyzed for SK activity using
D-erythro-sphingosine and ATP as substrates. SK activities given are
relative to the activity of mSK1aWT. Data shown are means of three
separate experiments with S.D.
108 S. Yokota et al. / FEBS Letters 578 (2004) 106–110In a previous report, calmodulin bound only the SK that
had undergone proper folding [22]. To examine whether
the decline in the SK activity of our mutants occurred as a
result of changes in the protein structure, we performed a
calmodulin-binding assay in accordance with that report.
We determined that calmodulin bound to the SK protein
in all the mSK1a mutants. Since this binding was in the pres-
ence of Ca2+ (Fig. 3), we also executed this assay in the pres-
ence of the calcium chelator EGTA as a control. We
observed no detectable bands in any of the mutants when0
10
20
30
40
A
C
0 50 100 150
-0.02
0.03
0.08
0.13
0.18
-0.1 0.41/[S]
1/
[v]
sp
hi
ng
os
in
e
ki
n
a
se
ac
tiv
ity
   
sp
hi
ng
os
in
e
ki
n
a
se
ac
tiv
ity
   
(pm
o
l/m
in
/µ
g)
Sph (µM)
0
10
20
30
40
0 200 400 600
ATP (µM)
-0.02
0.03
0.08
0.13
-0.01 0.041/[s]
1/[
v]
sp
hi
ng
os
in
e
ki
n
a
se
ac
tiv
ity
   
(pm
o
l/m
in
/µ
g)
sp
hi
ng
os
in
e
ki
n
a
se
ac
tiv
ity
   
-0.01
-0.1
Fig. 4. Michaelis–Menten and Lineweaver–Burk plots for mSK1a proteins. K
SK activities were measured using the various concentrations of Sph and the
plots). Kinetics of mSK1aWT (C) and mSK1aD177N (D) with another substrat
values toward ATP were exhibited. The data shown are means ± S.D. of foCa2+ was absent (Fig. 3), conﬁrming that the bands origi-
nally observed were not due to non-speciﬁc binding. These
results indicated that the mSK1a mutants had undergone
proper folding with no collapse in their structure due to
the mutagenesis.
3.2. Asp177ﬁ Asn177 mutation (mSK1aD177N) diminishes
the binding aﬃnity for Sph
In order to examine the aﬃnity of SKs for substrates, SK
activities were measured using various concentrations of Sph
(ﬁnal concentrations: 3, 5, 10, 17, 30, 50, 90 and 150 lM).
When the results were plotted and Km values for each enzyme
toward Sph were calculated by Lineweaver–Burk plot, we
could identify a gentle slope in the plot of mSK1aD177N (Fig.
4B) compared to wild type (Fig. 4A). The Km values for
mSK1aWT and mSK1aD177N toward Sph were 10.1 ± 0.7 andB
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ur independent experiments.
Table 1
Substrate kinetics of mSK1a mutants
mSK1a mutants Vmax (pmol/min/lg) Km
Sph (lM) ATP (lM)
Wild type 39.1 ± 0.7 10.1 ± 0.7 71.5 ± 10
D175N 18.1 ± 1.3 36.6 ± 8.1 77.4 ± 9.2
D177N 2.4 ± 1.0 108 ± 20 88.4 ± 5.0
E179Q 9.2 ± 0.2 25.7 ± 4.2 62.8 ± 6.5
E181Q 9.0 ± 1.2 10.2 ± 4.1 94.7 ± 13
These data are shown with S.D. by the four independent experiments.
S. Yokota et al. / FEBS Letters 578 (2004) 106–110 109108 ± 20 lM, respectively (Fig. 4A and B), a remarkable rise.
We were also able to conﬁrm slight increases in Km values for
mSK1aD175N (36.6 ± 8.1 lM) and mSK1aE179Q (25.7 ± 4.2
lM) (Table 1). This result indicated that a mutation abolishing
a negative charge, such as Asp177ﬁ Asn177, decreases the rec-
ognition ability of the enzyme for Sph, and that the Asp177 res-
idue, especially, is involved in the recognition of Sph.
Subsequently, we examined whether Asp177 was involved
only in the speciﬁc recognition of Sph. Using various concen-
trations of another substrate, ATP (ﬁnal concentrations: 30,
50, 90, 160, 280 and 500 lM), we again measured the SK activ-
ities and calculated the Km values. No diﬀerence was apparent
between the Km values of mSK1a
WT and mSK1aD177N for
ATP (Fig. 4C and D), indicating that the aﬃnity for ATP re-
mains unchanged after these mutations. We also conﬁrmed
that there were no changes in the aﬃnity for ATP in any of
the other mutants (mSK1aWT, mSK1aD175N, mSK1aE179Q
and mSK1aE181Q, shown in Table 1). Taken together, these re-
sults demonstrate that Asp177 is involved in the speciﬁc recog-
nition of Sph and also support the ﬁnding in Fig. 3 that each
mutant undergoes proper folding, since all exhibited activity
toward ATP.
3.3. Discussion
In this report, we demonstrated that the Asp177 residue,
which is highly conserved in SKs, is involved in the Sph-recog-
nition. In initial enzyme assays of mSK1a mutants carrying
substitutions in the C4 domain, mSK1aD177N carrying the
Asp177ﬁ Asn177 mutation exhibited a great decline in SK
activity (Fig. 2). Additionally, the substrate aﬃnity of this mu-
tant towards Sph decreased remarkably, with no change in the
aﬃnity towards ATP, indicating that the C4 domain (including
the Asp177 residue) is involved only in the speciﬁc recognition
of Sph (Fig. 4 and Table 1). We hypothesize that the negative
charge of Asp177 may interact with a positive charge of an ami-
no group in Sph, or that Asp177 may be involved in a hydrogen
bond with a hydroxyl group in Sph. However, the SK activity
did not disappear completely. Therefore, it is also probable
that in the recognition of Sph not only is the C4 domain in-
volved, but other regions of SK as well. We predicted that
the hydrophobic residues in the region adjacent to the C4 do-
main interact with the hydrophobic part of Sph. In fact, we
have conﬁrmed that a mutation in these hydrophobic residues
does destroy the SK activity (manuscript in preparation).
Although SKs and CERKs are representatives of a novel class
of lipid kinases and are not so well understood, we provide for
the ﬁrst time an account of the region involved in the Sph-
recognition. However, many things have not yet been ex-
plained, such as the mechanism of transferring the phosphate
group of ATP to Sph and structural information of the SKs.These remain for future study, perhaps using X-ray crystallo-
graphic analysis.Acknowledgment: This work was supported in part by a Grant-in Aid
for Scientiﬁc Research on Priority Areas (B) (12140201) from the min-
istry of Education, Culture, Sports, Science and Technology.References
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